Publications by authors named "Hratch Zokian"

Claim this Profile
A
Avoiding Misreading during Genetic Reprogramming in mRNA Display.
Gopal K Dubey, Peng-Hsun Chase Chen, Sabrina E Iskandar, Naga Garikiparthy, Hratch J Zokian

Chembiochem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.
Douglas G Johns, Louis-Charles Campeau, Puja Banka, An Bautmans, Tjerk Bueters, Hratch J Zokian

Circulation· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.
Thomas J Tucker, Mark W Embrey, Candice Alleyne, Rupesh P Amin, Alan Bass, Hratch J Zokian

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, Pravien Abeywickrema, Vijayalakshmi Agnani, Hratch Zokian

Cell Chem Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design.
Candice Alleyne, Rupesh P Amin, Bhavana Bhatt, Elisabetta Bianchi, J Craig Blain, Hratch J Zokian

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, Pravien Abeywickrema, Vijayalakshmi Agnani, Hratch Zokian

Cell Chem Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Assays for the Discovery of PCSK9 Autoprocessing Inhibitors.
Scott P Salowe, Lei Zhang, Hratch J Zokian, Jennifer J Gesell, Deborah L Zink

J Biomol Screen· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertension.
David R Bauman, Alan Whitehead, Lisa C Contino, Jisong Cui, Margarita Garcia-Calvo, Hratch J Zokian

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1.
Wanying Sun, Milana Maletic, Steven S Mundt, Kashmira Shah, Hratch Zokian

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome.
Milana Maletic, Aaron Leeman, Michael Szymonifka, Steven S Mundt, Hratch J Zokian

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Yuping Zhu, Steven H Olson, Anne Hermanowski-Vosatka, Steven Mundt, Kashmira Shah, Hratch Zokian

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenylcyclobutyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Yuping Zhu, Steven H Olson, Donald Graham, Gool Patel, Anne Hermanowski-Vosatka, Hratch Zokian

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Susan D Aster, Donald W Graham, Divya Kharbanda, Gool Patel, Mitree Ponpipom, Hratch Zokian

Bioorg Med Chem Lett· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.
Xin Gu, Jasminka Dragovic, Gloria C Koo, Sam L Koprak, Cheryl LeGrand, Hratch J Zokian

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening of 11beta-hydroxysteroid dehydrogenase type 1 in scintillation proximity assay format.
Kelli Solly, Steven S Mundt, Hratch J Zokian, Gloria Juy-Fang Ding, Anne Hermanowski-Vosatka

Assay Drug Dev Technol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis